Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.3.11ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.3.11SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.3.2ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-2627.44Singapore
BA.2.3.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.85ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.85SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.65ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.65SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.1.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.1.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BG.5ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BG.5SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.61ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.61SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.1.23ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.1.23SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BF.8ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BF.8SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.74ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.74SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.12ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.12SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BM.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BM.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.2.28ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.2.28SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.2.62ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.2.62SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.2.24ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.2.24SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.8ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.8SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.2.13.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.2.13.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BF.28ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BF.28SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.1.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.1.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BE.1.1.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BE.1.1.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
XAZORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
XAZSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BE.4ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BE.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.1.24ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.1.24SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.1.16ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.1.16SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.2.26ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.2.26SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used